CN101264154A - 一种中药口服制剂的制备方法 - Google Patents
一种中药口服制剂的制备方法 Download PDFInfo
- Publication number
- CN101264154A CN101264154A CNA2008100443733A CN200810044373A CN101264154A CN 101264154 A CN101264154 A CN 101264154A CN A2008100443733 A CNA2008100443733 A CN A2008100443733A CN 200810044373 A CN200810044373 A CN 200810044373A CN 101264154 A CN101264154 A CN 101264154A
- Authority
- CN
- China
- Prior art keywords
- preparation
- rhizoma
- parts
- crude drug
- chinese traditional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 87
- 238000002360 preparation method Methods 0.000 title claims abstract description 54
- 229940079593 drug Drugs 0.000 claims abstract description 63
- 239000000843 powder Substances 0.000 claims abstract description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000000203 mixture Substances 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 16
- 238000009472 formulation Methods 0.000 claims abstract description 14
- 239000000463 material Substances 0.000 claims abstract description 13
- 229920002472 Starch Polymers 0.000 claims abstract description 10
- 239000008107 starch Substances 0.000 claims abstract description 10
- 235000019698 starch Nutrition 0.000 claims abstract description 10
- 229920001353 Dextrin Polymers 0.000 claims abstract description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000000741 silica gel Substances 0.000 claims abstract description 9
- 239000000284 extract Substances 0.000 claims abstract description 5
- 241000218176 Corydalis Species 0.000 claims description 46
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 35
- 210000000582 semen Anatomy 0.000 claims description 17
- 239000012141 concentrate Substances 0.000 claims description 15
- 230000000694 effects Effects 0.000 claims description 15
- 238000007670 refining Methods 0.000 claims description 14
- 238000010298 pulverizing process Methods 0.000 claims description 12
- 238000003809 water extraction Methods 0.000 claims description 12
- 239000013067 intermediate product Substances 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 239000004375 Dextrin Substances 0.000 claims description 8
- 235000019425 dextrin Nutrition 0.000 claims description 8
- 229910002027 silica gel Inorganic materials 0.000 claims description 8
- 239000002671 adjuvant Substances 0.000 claims description 7
- 238000012216 screening Methods 0.000 claims description 6
- 241000283707 Capra Species 0.000 claims description 4
- 238000000889 atomisation Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 241000241550 Cyathula Species 0.000 claims description 2
- 230000006837 decompression Effects 0.000 claims description 2
- 239000002775 capsule Substances 0.000 abstract description 13
- 201000005569 Gout Diseases 0.000 abstract description 9
- 238000005516 engineering process Methods 0.000 abstract description 7
- 239000006187 pill Substances 0.000 abstract description 7
- 238000005469 granulation Methods 0.000 abstract description 4
- 230000003179 granulation Effects 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 238000000605 extraction Methods 0.000 abstract description 2
- 239000012535 impurity Substances 0.000 abstract description 2
- 239000002131 composite material Substances 0.000 abstract 1
- 230000007423 decrease Effects 0.000 abstract 1
- FYGDTMLNYKFZSV-MRCIVHHJSA-N dextrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](CO)OC(O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-MRCIVHHJSA-N 0.000 abstract 1
- 229910021487 silica fume Inorganic materials 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 19
- 235000019634 flavors Nutrition 0.000 description 19
- 239000012567 medical material Substances 0.000 description 19
- 239000008187 granular material Substances 0.000 description 15
- 239000000706 filtrate Substances 0.000 description 11
- 239000008194 pharmaceutical composition Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 238000007689 inspection Methods 0.000 description 9
- 239000011230 binding agent Substances 0.000 description 7
- 239000003826 tablet Substances 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000003172 expectorant agent Substances 0.000 description 5
- 230000003419 expectorant effect Effects 0.000 description 5
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical class [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000001694 spray drying Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000005550 wet granulation Methods 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- 201000001431 Hyperuricemia Diseases 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229910052785 arsenic Inorganic materials 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 201000006334 interstitial nephritis Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 238000011112 process operation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000004144 purine metabolism Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810044373 CN101264154B (zh) | 2008-05-08 | 2008-05-08 | 一种中药口服制剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810044373 CN101264154B (zh) | 2008-05-08 | 2008-05-08 | 一种中药口服制剂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101264154A true CN101264154A (zh) | 2008-09-17 |
CN101264154B CN101264154B (zh) | 2013-02-13 |
Family
ID=39986994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200810044373 Active CN101264154B (zh) | 2008-05-08 | 2008-05-08 | 一种中药口服制剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101264154B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102228245A (zh) * | 2011-06-24 | 2011-11-02 | 江苏康迪生物科技有限公司 | 一种以蛹虫草子实体超微纯粉制备颗粒剂及其制备方法 |
CN102579601A (zh) * | 2011-04-06 | 2012-07-18 | 四川师范大学 | 一种治疗类风湿性关节炎的药物组合物及其制备方法和用途 |
CN103565994A (zh) * | 2013-11-27 | 2014-02-12 | 张文礼 | 一种治疗痛风性关节炎的药物及其制备方法 |
CN104224867A (zh) * | 2014-09-28 | 2014-12-24 | 重庆和平制药有限公司 | 一种金钱草无糖颗粒及其制备方法 |
CN115969941A (zh) * | 2023-02-13 | 2023-04-18 | 许昌市中心医院 | 痛风膏 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1628768A (zh) * | 2004-08-26 | 2005-06-22 | 成都中汇制药有限公司 | 一种治疗痛风病及其症状的药物 |
-
2008
- 2008-05-08 CN CN 200810044373 patent/CN101264154B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1628768A (zh) * | 2004-08-26 | 2005-06-22 | 成都中汇制药有限公司 | 一种治疗痛风病及其症状的药物 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579601A (zh) * | 2011-04-06 | 2012-07-18 | 四川师范大学 | 一种治疗类风湿性关节炎的药物组合物及其制备方法和用途 |
CN102228245A (zh) * | 2011-06-24 | 2011-11-02 | 江苏康迪生物科技有限公司 | 一种以蛹虫草子实体超微纯粉制备颗粒剂及其制备方法 |
CN103565994A (zh) * | 2013-11-27 | 2014-02-12 | 张文礼 | 一种治疗痛风性关节炎的药物及其制备方法 |
CN104224867A (zh) * | 2014-09-28 | 2014-12-24 | 重庆和平制药有限公司 | 一种金钱草无糖颗粒及其制备方法 |
CN104224867B (zh) * | 2014-09-28 | 2017-08-08 | 重庆和平制药有限公司 | 一种金钱草无糖颗粒及其制备方法 |
CN115969941A (zh) * | 2023-02-13 | 2023-04-18 | 许昌市中心医院 | 痛风膏 |
Also Published As
Publication number | Publication date |
---|---|
CN101264154B (zh) | 2013-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1947757B (zh) | 地黄叶提取物及其制备方法和用途、用该提取物制备的药物 | |
CN102271698B (zh) | 药物组合物及其在制备药剂中的用途 | |
CN101264154B (zh) | 一种中药口服制剂的制备方法 | |
CN102940695B (zh) | 治疗痛风的药物组合物 | |
CN103223104B (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN102973719A (zh) | 一种具有润肠通便功能的中药保健食品及制备方法 | |
CN101011562B (zh) | 参芪温胆汤新剂型及其生产方法 | |
CN102657736B (zh) | 一种治疗类风湿性关节炎的药物组合物及其制备方法 | |
CN102526517B (zh) | 一种治疗感冒的热毒清中药组合物及其制备方法 | |
CN102228547B (zh) | 一种中药组合物在制备治疗胰腺炎和/或胆囊炎药物中的应用 | |
CN106692744A (zh) | 一种治疗糖尿病的中药组合物 | |
CN102940750B (zh) | 治疗痛风的药物组合物 | |
CN100518781C (zh) | 一种制备泻肝安神口服制剂的方法及制成的制剂 | |
CN111329983B (zh) | 一种含有忧遁草的中药组合物及其制备方法 | |
CN1060663C (zh) | 复方藏茵陈成药 | |
CN1314434C (zh) | 清降制剂药物及其制备方法 | |
CN108837084A (zh) | 一种中药制剂及其制备方法 | |
CN102406910A (zh) | 强免疫、防治风湿、类风湿、椎间盘突出的组合物 | |
CN1062844A (zh) | 防治爱滋病中药方剂的制备方法 | |
CN1194733C (zh) | 一种治疗甲亢的药物及制备方法 | |
CN107625894A (zh) | 一种复方参芪分散片的制备方法 | |
CN108543038B (zh) | 一种化瘀止血的中药组合物及其制备方法和应用 | |
CN101607020A (zh) | 一种治疗荨麻疹的药物 | |
CN106491747B (zh) | 虫草芪参胶囊的制备及质量标准检测方法 | |
CN1330338C (zh) | 用于晚期癌症病人培补元气的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SICHUAN SUNNYHOPE PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZHONGHUI PHARMACEUTICAL CO., LTD., CHENGDU CITY Effective date: 20120601 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 610036 CHENGDU, SICHUAN PROVINCE TO: 610041 CHENGDU, SICHUAN PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20120601 Address after: No. 3 high tech Zone Gaopeng road in Chengdu city of Sichuan Province in 610041 Applicant after: Sichuan Sunnyhope Pharmaceutical Co., Ltd. Address before: 610036 No. 30 Shu West Road, Sichuan, Chengdu Applicant before: Zhonghui Pharmaceutical Co., Ltd., Chengdu City |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of Chinese medicine oral preparation Effective date of registration: 20141120 Granted publication date: 20130213 Pledgee: China Huarong Asset Management Limited by Share Ltd Sichuan branch Pledgor: Sichuan Sunnyhope Pharmaceutical Co., Ltd. Registration number: 2014510000035 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20180209 Granted publication date: 20130213 Pledgee: China Huarong Asset Management Limited by Share Ltd Sichuan branch Pledgor: Sichuan Sunnyhope Pharmaceutical Co., Ltd. Registration number: 2014510000035 |